These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22305847)

  • 21. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
    Saunders JT; Nambi V; de Lemos JA; Chambless LE; Virani SS; Boerwinkle E; Hoogeveen RC; Liu X; Astor BC; Mosley TH; Folsom AR; Heiss G; Coresh J; Ballantyne CM
    Circulation; 2011 Apr; 123(13):1367-76. PubMed ID: 21422391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.
    Olson NC; Cushman M; Judd SE; Kissela BM; Safford MM; Howard G; Zakai NA
    J Thromb Haemost; 2017 Jun; 15(6):1086-1094. PubMed ID: 28393470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.
    Bansal N; Katz R; Robinson-Cohen C; Odden MC; Dalrymple L; Shlipak MG; Sarnak MJ; Siscovick DS; Zelnick L; Psaty BM; Kestenbaum B; Correa A; Afkarian M; Young B; de Boer IH
    JAMA Cardiol; 2017 Mar; 2(3):314-318. PubMed ID: 28002548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
    Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study.
    Paul Chubb SA; Davis WA; Peters KE; Davis TM
    Cardiovasc Diabetol; 2016 Oct; 15(1):143. PubMed ID: 27716263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex Differences in the Association Between Pentraxin 3 and Cognitive Decline: The Cardiovascular Health Study.
    Miller LM; Jenny NS; Rawlings AM; Arnold AM; Fitzpatrick AL; Lopez OL; Odden MC
    J Gerontol A Biol Sci Med Sci; 2020 Jul; 75(8):1523-1529. PubMed ID: 31808814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.
    Williams ES; Shah SJ; Ali S; Na BY; Schiller NB; Whooley MA
    Eur J Heart Fail; 2008 Jan; 10(1):63-9. PubMed ID: 18160340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
    Bluemke DA; Kronmal RA; Lima JA; Liu K; Olson J; Burke GL; Folsom AR
    J Am Coll Cardiol; 2008 Dec; 52(25):2148-55. PubMed ID: 19095132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.
    Stamatelopoulos K; Sibbing D; Rallidis LS; Georgiopoulos G; Stakos D; Braun S; Gatsiou A; Sopova K; Kotakos C; Varounis C; Tellis CC; Kastritis E; Alevizaki M; Tselepis AD; Alexopoulos P; Laske C; Keller T; Kastrati A; Dimmeler S; Zeiher AM; Stellos K
    J Am Coll Cardiol; 2015 Mar; 65(9):904-16. PubMed ID: 25744007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
    Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND
    Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
    Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
    J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of plasma lactate with incident cardiovascular outcomes: the ARIC Study.
    Matsushita K; Williams EK; Mongraw-Chaffin ML; Coresh J; Schmidt MI; Brancati FL; Hoogeveen RC; Ballantyne CM; Young JH
    Am J Epidemiol; 2013 Aug; 178(3):401-9. PubMed ID: 23817916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive affect and survival in patients with stable coronary heart disease: findings from the Heart and Soul Study.
    Hoen PW; Denollet J; de Jonge P; Whooley MA
    J Clin Psychiatry; 2013 Jul; 74(7):716-22. PubMed ID: 23945449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study.
    Park M; Maristany D; Huang D; Shlipak MG; Whooley M
    Atherosclerosis; 2017 Aug; 263():68-73. PubMed ID: 28601698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    Burger PM; Koudstaal S; Mosterd A; Fiolet ATL; Teraa M; van der Meer MG; Cramer MJ; Visseren FLJ; Ridker PM; Dorresteijn JAN;
    J Am Coll Cardiol; 2023 Aug; 82(5):414-426. PubMed ID: 37495278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.
    Baragetti A; Knoflach M; Cuccovillo I; Grigore L; Casula M; Garlaschelli K; Mantovani A; Wick G; Kiechl S; Willeit J; Bottazzi B; Catapano AL; Norata GD
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):518-23. PubMed ID: 24462365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.